Cure My Disease

Don't miss your cure!

 Log in / Sign up

Iron-Busting drug tested as Parkinson's slower

NCT ID NCT02655315

Completed Disease control Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a drug called deferiprone, which removes extra iron from the body, could slow down Parkinson's disease. 372 adults with early Parkinson's took either the drug or a placebo for 9 months. The goal was to see if the drug could reduce both movement and non-movement symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE

Contacts and locations

Locations

  • AP-HP, Hôpital Pitié-Salpêtrière

    Paris, France

  • Acadamic central center, Amsterdam

    Amsterdam, Netherlands

  • CHU Pellegrin

    Bordeaux, France

  • CHU de Strasbourg, Hôpital de Hautepierre

    Strasbourg, France

  • CHU la TIMONE

    Marseille, France

  • Cambridge University Hospital

    Cambridge, United Kingdom

  • Centro Hospitalar Lisboa Norte

    Lisbon, Portugal

  • Centro Hospitalar do Alto Ave

    Guimarães, Portugal

  • Centro Hospitalar e universitario de Coimbra

    Coimbra, Portugal

  • Charles University

    Prague, Czechia

  • Christian-albrechts universität zu kiel

    Kiel, Germany

  • Chu Purpan

    Toulouse, France

  • Hospital Clinic Universitari de Barcelona

    Barcelona, Spain

  • Hospital de Bellvitge

    Barcelona, Spain

  • Hospital de la Santa Creu i Sant Pau

    Barcelona, Spain

  • Hôpital Montpied

    Clermont-Ferrand, France

  • Hôpital Salengro, CHRU

    Lille, France

  • Hôpital Wertheimer

    Bron, France

  • Klinik und Poliklinik für Neurologie der Universitätsmedizin Rostock

    Rostock, Germany

  • Medizinische Universitat Innsbruck

    Innsbruck, Austria

  • Newcastle University

    Newcastle, United Kingdom

  • Radboud university medical center

    Nijmegen, Netherlands

  • University Hospital, Saarland University

    Homburg, Germany

  • University of Glasgow

    Glasgow, United Kingdom

  • Univerzita Karlova V Praze

    Prague, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.